logo
Select company
Select metric
-17.1%Return on Equity
VS
Market
30
Sector
69
Industry
87
History
55
$ 34.99Close
$ 18.76 - $ 39.72 52-Week Range
Ticker Information

Ticker

XOMA

Company Name

XOMA ROYALTY CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XOMA ROYALTY CORP - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XOMA - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 72.44M$ -12.39M-17.1%
3/31/2025$ 84.63M$ -5.59M-6.61%
12/31/2024$ 81.92M$ -19.29M-23.55%
9/30/2024$ 84.81M$ -34.07M-40.17%
6/30/2024$ 99.99M$ -22.33M-22.33%
3/31/2024$ 82.34M$ -45.09M-54.75%
12/31/2023$ 88.72M$ -46.3M-52.19%
9/30/2023$ 105.96M$ -32.17M-30.36%
6/30/2023$ 110.12M$ -30.84M-28%
3/31/2023$ 114.53M$ -30.11M-26.29%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XOMA ROYALTY CORP's latest trailing twelve months (TTM) ROE stands at -33.42%.
  • Over the past 5 years, XOMA ROYALTY CORP's average ROE has been -14.15%.
  • The median ROE for XOMA ROYALTY CORP during this period was -17.65%
  • XOMA ROYALTY CORP reached its highest ROE over the past 5 years at 15.39%.
  • The lowest ROE recorded by XOMA ROYALTY CORP in the same timeframe -54.75%

XOMA ROYALTY CORP's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
SCPH : SCPHARMACEUTICALS INC -LXRX : LEXICON PHARMACEUTICALS INC -93.19%GOSS : GOSSAMER BIO INC -CDXS : CODEXIS INC -116.8%EDIT : EDITAS MEDICINE INC -1234.35%FENC : FENNEC PHARMACEUTICALS INC -AQST : AQUESTIVE THERAPEUTICS INC -FHTX : FOGHORN THERAPEUTICS INC -SPRO : SPERO THERAPEUTICS INC -163.28%CELU : CELULARITY INC -

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for XOMA ROYALTY CORP is calculated as follows: Net Inc. Cmn. [ $ -12.71M ] / Equity [ $ 38.04M ]
(=) ROE [ -33.42% ]

XOMA - Return on Equity, Last 5 years

-54.75%

Minimum

Mar 31, 2024

15.39%

Maximum

Dec 31, 2020

-14.15%

Average

-17.65%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.68%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.68%